Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008690 · ClinicalTrials.gov registry record
MRI of the TMJ in Patients With DJD
A clinical trial of Degenerative Joint Disease and Control Subjects, sponsored by University of Minnesota.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07008690: Active study of Degenerative Joint Disease and Control Subjects, sponsored by University of Minnesota.
NCT07008690 is a study of Degenerative Joint Disease and Control Subjects that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 40 participants, below the 432-participant average among 4 other Degenerative Joint Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07008690, a study of Degenerative Joint Disease and Control Subjects, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational research is comparative in design, that is assessing the change in qMRI measures in degenerative changes of the TMJ in patients diagnosed with DJD. These patients will be imaged multiple times over the course of 18 months, using clinical 3T MRI scanners located at the Center for Magnetic Resonance Research (CMRR), and their findings will be compared to controls; individuals who are not diagnosed with DJD. No investigational agents or MRI contrast agents will be used.
Primary Outcome
We will assess these changes between baseline MRI and multiple MRI scanning session over the course of 18 months. We will group patients who do (case group) and do not (control group) have clinical progression of DJD based on their existing CT scans and/or radiograph imaging acquired by their clinician to confirm their diagnosis. These findings will be evaluated through subjective observations and the ability to identify various anatomical structures. Additionally, intra- and inter-rater reliabi
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging
- DIAGNOSTIC_TEST MRI
Study Locations (1)
Minnesota
- Orofacial MRI Center at UMN - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-17 |
| Est. Completion | 2027-11-28 |
What the registry record for NCT07008690 still lists
NCT07008690 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 432-participant average among 4 other Degenerative Joint Disease trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Degenerative Joint Disease appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT07008690 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07008690 about?
NCT07008690 is a clinical study titled "MRI of the TMJ in Patients With DJD". This observational research is comparative in design, that is assessing the change in qMRI measures in degenerative changes of the TMJ in patients diagnosed with DJD. These patients will be imaged multiple times over the course of 18 months, using clinical 3T MRI scanners located at the Center for M...
What is the current status of trial NCT07008690?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2025-04-17. Estimated completion is 2027-11-28.
What conditions does trial NCT07008690 study?
This clinical trial studies the following conditions: Degenerative Joint Disease, Control Subjects.
What interventions are being tested in trial NCT07008690?
The interventions under investigation include: Magnetic Resonance Imaging (DIAGNOSTIC_TEST), MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07008690?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07008690 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Joint Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
ACTIVE NOT RECRUITING
-
R3 Delta Ceramic Acetabular System PAS U.S.
COMPLETED
-
Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI